Toshihiko Honkura
Chief Executive Officer at Quantum Biosystems, Inc.
Profile
Toshihiko Honkura is the founder of Quantum Biosystems, Inc., a company founded in 2013, where he holds the title of President & Chief Executive Officer.
He is currently working as a Director at Impute, Inc. Mr. Honkura previously worked as a Manager at McKinsey & Co. (Japan).
He has an MBA from The Trustees of Columbia University in The City of New York and a graduate degree from the University of Tokyo.
Toshihiko Honkura active positions
| Companies | Position | Start |
|---|---|---|
Quantum Biosystems, Inc.
 Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Chief Executive Officer | 2013-01-06 |
Impute, Inc.
 Impute, Inc. Packaged SoftwareTechnology Services Impute Inc. is a Japanese company that focuses on digital therapeutics with AI-based solutions. The company is based in Tokyo, Japan. The company has developed an autism therapy app that provides a digital-therapeutic program for children with autism spectrum disorder (ASD). Impute Inc. was founded in 2017 by Hirofumi Hamanaka, Kunal A. The CEO is Mayank Singh. | Director/Board Member | - |
Former positions of Toshihiko Honkura
| Companies | Position | End |
|---|---|---|
| McKinsey & Co. (Japan) | Corporate Officer/Principal | - |
Training of Toshihiko Honkura
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Tokyo | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| McKinsey & Co. (Japan) | |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
Impute, Inc.
Impute, Inc. Packaged SoftwareTechnology Services Impute Inc. is a Japanese company that focuses on digital therapeutics with AI-based solutions. The company is based in Tokyo, Japan. The company has developed an autism therapy app that provides a digital-therapeutic program for children with autism spectrum disorder (ASD). Impute Inc. was founded in 2017 by Hirofumi Hamanaka, Kunal A. The CEO is Mayank Singh. | Technology Services |
- Stock Market
- Insiders
- Toshihiko Honkura
